First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Translational Medicine

Topics

Medicine

Cancer Oncology

Immunology

Pathology

Internal Medicine

Show all topics

DOI

10.1186/s12967-018-1507-6

License

CC-BY

Other Formats

PDF